C
AVNS

Covestor’s Avanos Medical AVNS Stock Holding History

Covestor’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9K Sell
392
-324
-45% -$7.59K 0.01% 1643
2026
Q1 		$10K Buy
716
+61
+9% +$822 0.01% 1378
2025
Q4 		$7K Buy
655
+3
+0.5% +$34 ﹤0.01% 1761
2025
Q3 		$7K Buy
652
+648
+16,200% +$7.59K ﹤0.01% 1786
2025
Q2 		$0 Sell
4
-288
-99% -$3.62K ﹤0.01% 2200
2025
Q1 		$4K Buy
292
+14
+5% +$219 ﹤0.01% 1745
2024
Q4 		$4K Sell
278
-19
-6% -$376 ﹤0.01% 1743
2024
Q3 		$7K Buy
297
+6
+2% +$137 ﹤0.01% 1684
2024
Q2 		$6K Buy
291
+1
+0.3% +$19 ﹤0.01% 1740
2024
Q1 		$6K Buy
290
+14
+5% +$271 ﹤0.01% 1763
2023
Q4 		$6K Buy
276
+45
+19% +$929 ﹤0.01% 1745
2023
Q3 		$5K Buy
231
+6
+3% +$136 ﹤0.01% 1712
2023
Q2 		$6K Buy
225
+66
+42% +$1.74K ﹤0.01% 1666
2023
Q1 		$5K Sell
159
-24
-13% -$697 ﹤0.01% 1547
2022
Q4 		$5K Buy
183
+37
+25% +$905 ﹤0.01% 1552
2022
Q3 		$3K Buy
146
+90
+161% +$2.35K ﹤0.01% 1600
2022
Q2 		$2K Buy
56
+46
+460% +$1.32K ﹤0.01% 1586
2022
Q1 		$0 Sell
10
-58
-85% -$1.87K ﹤0.01% 2094
2021
Q4 		$2K Buy
+68
New +$2.2K ﹤0.01% 1517

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Covestor's AVNS Position: Q2 2026 in Review

Covestor reduced its Avanos Medical (AVNS) stake by 45% in Q2 2026, selling an estimated $7.59K and leaving 392 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #1643.

Covestor first reported a position in AVNS in Q4 2021 and has held it in 19 quarters since. The position peaked at $10K in Q1 2026. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Covestor held 392 shares of Avanos Medical worth $9K as of Q2 2026.
  • Covestor sold 324 Avanos Medical shares in Q2 2026, an estimated $7.59K.
  • Avanos Medical made up 0.01% of Covestor's portfolio in Q2 2026, its #1643 holding.
  • Covestor first reported a position in Avanos Medical in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Avanos Medical position peaked at $10K in Q1 2026.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.